Bullous pemphigoid Market by Drug Class, Route Of Administration, End-User, Age Group, Treatment Type, Severity, Diagnosis Test - Global Forecast 2025-2030- Product Image

Sale

Bullous pemphigoid Market by Drug Class, Route Of Administration, End-User, Age Group, Treatment Type, Severity, Diagnosis Test - Global Forecast 2025-2030

Report
190 Pages
October 2024
Region: Global
360iResearch™
ID: 6011507

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Bullous pemphigoid Market grew from USD 345.28 million in 2023 to USD 358.38 million in 2024. It is expected to continue growing at a CAGR of 5.60%, reaching USD 505.68 million by 2030.

Bullous pemphigoid is an autoimmune blistering disorder primarily affecting the elderly, characterized by large, fluid-filled blisters on areas of the skin that often flex or fold. Market scope extends beyond treatment to encompass research into new therapeutics, diagnostics, patient management solutions, and supportive care. The necessity of advancements in this market is driven by the need for effective treatments with minimal side effects, considering the chronic nature and age-associated vulnerability of affected individuals. The application scope involves pharmaceutical innovation, healthcare service improvements, and patient support systems, with end-use spanning hospitals, specialty dermatology clinics, and research institutions focused on autoimmune disorders.

Key growth factors include the rising prevalence of autoimmune diseases, increased awareness, and improved diagnostic techniques, enhancing early detection and management. Opportunities exist in developing novel biotechnological therapies, including biologics and personalized medicine approaches, leveraging advancements in genomics and immunology. Companies are recommended to focus on strategic collaborations with research institutions and healthcare providers to innovate more precise and less invasive therapies, and to enhance disease monitoring and patient care technologies.

However, the market faces limitations such as high costs of treatment development, complexities of regulatory approvals, and potential side effects of existing therapies that deter market penetration. Additionally, limited awareness among healthcare providers in developing regions hampers diagnosis and access to treatment.

Innovative areas include exploring biomarkers for early detection, leveraging digital health technologies for patient monitoring and adherence, and advancing gene therapy and CRISPR research tailored to autoimmune profiles. The market’s nature remains highly competitive and research-driven, dominated by significant pharmaceutical players and biotechnology innovators. Strategic investment in R&D and collaborations for holistic care solutions can position new players for sustainable growth while addressing current challenges in disease management and treatment effectiveness.

Understanding Market Dynamics in the Bullous pemphigoid Market

The Bullous pemphigoid Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising healthcare expenditure and supportive government policies enhancing access to bullous pemphigoid treatments
- Expansion of healthcare infrastructure in emerging economies facilitating market penetration and growth
- Growing number of clinical trials for bullous pemphigoid treatments increasing market competitiveness
Market Restraints
- Lack of medical professionals specializing in bullous pemphigoid affecting market growth
Market Opportunities
- Implementation of advanced diagnostic tools to improve early detection of bullous pemphigoid
- Strategic partnerships between pharmaceutical companies and research institutes for bullous pemphigoid
Market Challenges
- Limited availability of advanced diagnostic tools for early detection in bullous pemphigoid market

Exploring Porter’s Five Forces for the Bullous pemphigoid Market

Porter’s Five Forces framework further strengthens the insights of the Bullous pemphigoid Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bullous pemphigoid Market

External macro-environmental factors deeply influence the performance of the Bullous pemphigoid Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bullous pemphigoid Market

The Bullous pemphigoid Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bullous pemphigoid Market

The Bullous pemphigoid Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bullous pemphigoid Market

The Bullous pemphigoid Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bullous pemphigoid Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Alexion Pharmaceuticals, Almirall, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Dermira, Eli Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline, Horizon Therapeutics, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi, Takeda Pharmaceutical Company, and UCB S.A..

Market Segmentation & Coverage

This research report categorizes the Bullous pemphigoid Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class
- Biologics
  - Rituximab
- Corticosteroids
  - Systemic Corticosteroids
  - Topical Corticosteroids
- Immunosuppressants
  - Azathioprine
  - Methotrexate
  - Mycophenolate Mofetil
Route Of Administration
- Intravenous
- Oral
- Topical
End-User
- Clinics
- Home Care
- Hospitals
  - Private Hospitals
  - Public Hospitals
Age Group
- Adults
- Geriatric
- Pediatric
Treatment Type
- First-Line Treatment
- Maintenance Treatment
- Second-Line Treatment
Severity
- Mild
- Moderate
- Severe
Diagnosis Test
- Biopsy
- Direct Immunofluorescence
- Elisa
- Indirect Immunofluorescence

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising healthcare expenditure and supportive government policies enhancing access to bullous pemphigoid treatments
5.1.1.2. Expansion of healthcare infrastructure in emerging economies facilitating market penetration and growth
5.1.1.3. Growing number of clinical trials for bullous pemphigoid treatments increasing market competitiveness
5.1.2. Restraints
5.1.2.1. Lack of medical professionals specializing in bullous pemphigoid affecting market growth
5.1.3. Opportunities
5.1.3.1. Implementation of advanced diagnostic tools to improve early detection of bullous pemphigoid
5.1.3.2. Strategic partnerships between pharmaceutical companies and research institutes for bullous pemphigoid
5.1.4. Challenges
5.1.4.1. Limited availability of advanced diagnostic tools for early detection in bullous pemphigoid market
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Bullous pemphigoid Market, by Drug Class

6.1. Introduction
6.2. Biologics
6.2.1. Rituximab
6.3. Corticosteroids
6.3.1. Systemic Corticosteroids
6.3.2. Topical Corticosteroids
6.4. Immunosuppressants
6.4.1. Azathioprine
6.4.2. Methotrexate
6.4.3. Mycophenolate Mofetil

7. Bullous pemphigoid Market, by Route Of Administration

7.1. Introduction
7.2. Intravenous
7.3. Oral
7.4. Topical

8. Bullous pemphigoid Market, by End-User

8.1. Introduction
8.2. Clinics
8.3. Home Care
8.4. Hospitals
8.4.1. Private Hospitals
8.4.2. Public Hospitals

9. Bullous pemphigoid Market, by Age Group

9.1. Introduction
9.2. Adults
9.3. Geriatric
9.4. Pediatric

10. Bullous pemphigoid Market, by Treatment Type

10.1. Introduction
10.2. First-Line Treatment
10.3. Maintenance Treatment
10.4. Second-Line Treatment

11. Bullous pemphigoid Market, by Severity

11.1. Introduction
11.2. Mild
11.3. Moderate
11.4. Severe

12. Bullous pemphigoid Market, by Diagnosis Test

12.1. Introduction
12.2. Biopsy
12.3. Direct Immunofluorescence
12.4. Elisa
12.5. Indirect Immunofluorescence

13. Americas Bullous pemphigoid Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Bullous pemphigoid Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Bullous pemphigoid Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. BULLOUS PEMPHIGOID MARKET RESEARCH PROCESS
FIGURE 2. BULLOUS PEMPHIGOID MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2023 VS 2030 (%)
FIGURE 17. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2023 VS 2030 (%)
FIGURE 19. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. BULLOUS PEMPHIGOID MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. BULLOUS PEMPHIGOID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. BULLOUS PEMPHIGOID MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BULLOUS PEMPHIGOID MARKET DYNAMICS
TABLE 7. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY RITUXIMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SYSTEMIC CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TOPICAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AZATHIOPRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MYCOPHENOLATE MOFETIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY FIRST-LINE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MAINTENANCE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SECOND-LINE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY INDIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 82. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 83. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 85. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 92. CANADA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 139. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 141. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 142. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 143. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 149. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 150. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 151. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 152. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 153. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 154. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 160. INDIA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 172. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 173. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 174. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 175. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 176. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 182. JAPAN BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 238. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 239. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 240. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 241. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 282. DENMARK BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 283. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 284. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 285. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 286. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 287. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 293. EGYPT BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 294. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 295. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 296. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 297. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 298. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 304. FINLAND BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 305. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 306. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 307. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 308. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 309. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 310. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 314. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 315. FRANCE BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 316. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 317. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 318. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 319. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 320. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 323. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 324. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 325. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 326. GERMANY BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 338. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 339. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 340. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 341. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 342. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 343. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 344. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 345. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 346. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 347. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 348. ITALY BULLOUS PEMPHIGOID MARKET SIZE, BY DIAGNOSIS TEST, 2018-2030 (USD MILLION)
TABLE 349. NETHERLANDS BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 350. NETHERLANDS BULLOUS PEMPHIGOID MARKET SI

Companies Mentioned

The leading players in the Bullous pemphigoid market, which are profiled in this report, include:

AbbVie
Alexion Pharmaceuticals
Almirall
Amgen
AstraZeneca
Biogen
Bristol-Myers Squibb
Dermira
Eli Lilly and Company
F. Hoffmann-La Roche
GlaxoSmithKline
Horizon Therapeutics
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Regeneron Pharmaceuticals
Sanofi
Takeda Pharmaceutical Company
UCB S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	190
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 358.38 Million
Forecasted Market Value ( USD ) by 2030	$ 505.68 Million
Compound Annual Growth Rate	5.6%
Regions Covered	Global
No. of Companies Mentioned	21

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Bullous pemphigoid Market

Exploring Porter’s Five Forces for the Bullous pemphigoid Market

Applying PESTLE Analysis to the Bullous pemphigoid Market

Analyzing Market Share in the Bullous pemphigoid Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bullous pemphigoid Market

Strategic Recommendations for Success in the Bullous pemphigoid Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Bullous Pemphigoid Market Report and Forecast 2024-2032

Bullous Pemphigoid Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Pemphigus Vulgaris (PV) - Market Insight, Epidemiology and Market Forecast - 2034

FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis